CBD Life Sciences Inc.
CBDL · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $127 | $7 | -$8 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $204 | $0 | $0 | $204 |
| Inventory | $40 | $32 | $15 | $10 |
| Other Curr. Assets | $0 | $204 | $204 | $0 |
| Total Curr. Assets | $371 | $243 | $211 | $232 |
| Property Plant & Equip (Net) | $17 | $32 | $46 | $60 |
| Goodwill | $100 | $100 | $100 | $100 |
| Intangibles | $5 | $10 | $14 | $18 |
| Long-Term Investments | $18 | $18 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $5 | $5 | $5 |
| Total NC Assets | $145 | $164 | $164 | $183 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $517 | $407 | $376 | $415 |
| Liabilities | – | – | – | – |
| Payables | $67 | $0 | $0 | $51 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $14 | $14 | $40 |
| Total Curr. Liab. | $81 | $14 | $14 | $91 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81 | $14 | $14 | $91 |
| Equity | – | – | – | – |
| Pref Stock | $66 | $66 | $66 | $66 |
| Common Stock | $4,398 | $4,366 | $4,263 | $4,121 |
| Retained Earnings | -$15,357 | -$15,319 | -$14,978 | -$14,682 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $436 | $393 | $362 | $325 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $517 | $407 | $376 | $415 |
| Net Debt | -$127 | -$7 | $8 | -$18 |